A genome-wide association study for malignant mesothelioma risk

Lung Cancer

Volumn 82, Issue 1, 2013, Pages 1-8

  Cadby, Gemma ^a   Mukherjee, Sutapa ^b,c   Musk, A W ^d,e   Reid, Alison ^f   Garlepp, Mike ^g   Dick, Ian ^e   Robinson, Cleo ^e   Hui, Jennie ^a,h   Fiorito, Giovanni ^i,n   Guarrera, Simonetta ⁱ   Beilby, John ^a,h   Melton, Phillip E ^a   Moses, Eric K ^a   Ugolini, Donatella ^j   Mirabelli, Dario ^k   Bonassi, Stefano ^l   Magnani, Corrado ^k,m   Dianzani, Irma ^k,m   Matullo, Giuseppe ^i,n   Robinson, Bruce ^d,e   Creaney, Jenette ^d,e   Palmer, Lyle J ^o,p   more..

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f PATHWEST LABORATORY MEDICINE   (Australia)

^g CURTIN UNIVERSITY   (Australia)

^h PATHWEST LABORATORY MEDICINE   (Australia)

ⁱ Human Genetics Foundation   (Italy)

^j UNIVERSITY OF GENOA   (Italy)

^k UNIVERSITY OF TURIN   (Italy)

^l IRCCS SAN RAFFAELE PISANA   (Italy)

^m UNIVERSITY OF EASTERN PIEDMONT   (Italy)

ⁿ UNIVERSITY OF TURIN   (Italy)

^o ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^p MOUNT SINAI HOSPITAL   (Canada)

more..

Author keywords

Asbestos; Case control studies; Genetics; Genome wide association study; Mesothelioma

Indexed keywords

ASBESTOS;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER RISK; CASE CONTROL STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MESOTHELIUM CELL; PRIORITY JOURNAL; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM;

ASBESTOS; CASE-CONTROL STUDIES; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MESOTHELIOMA;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOGLOBULINS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RAS GUANINE NUCLEOTIDE EXCHANGE FACTORS; RISK FACTORS;

EID: 84884412426     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.04.018     Document Type: Article

References (35)

1. Carbone M., Baris Y.I., Bertino P., Brass B., Comertpay S., Dogan A.U., et al. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc Natl Acad Sci USA 2011, 108:13618-13623.
2. Emri S., Demir A., Dogan M., Akay H., Bozkurt B., Carbone M., et al. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett 2002, 127:251-257.
3. Goodman J.E., Nascarella M.A., Valberg P.A. Ionizing radiation: a risk factor for mesothelioma. Cancer Causes Control 2009, 20:1237-1254.
4. Jamrozik E., de Klerk N., Musk A.W. Asbestos-related disease. Intern Med J 2011, 41:372-380.
5. Milano M.T., Zhang H. Malignant pleural mesothelioma: a population-based study of survival. J Thorac Oncol 2010, 5:1841-1848.
6. Christensen B.C., Godleski J.J., Roelofs C.R., Longacker J.L., Bueno R., Sugarbaker D.J., et al. Asbestos burden predicts survival in pleural mesothelioma. Environ Health Perspect 2008, 116:723-726.
7. Robinson B.W., Musk A.W., Lake R.A. Malignant mesothelioma. Lancet 2005, 366:397-408.
8. Musk A.W., Olsen N., Alfonso H., Reid A., Mina R., Franklin P., et al. Predicting survival in malignant mesothelioma. Eur Respir J 2011, 38:1420-1424.
9. National Occupational Health and Safety Commission The Incidence of Mesothelioma in Australia 1999 to 2001-AUSTRALIAN MESOTHELIOMA REGISTER REPORT 2004 2004.
10. Dogan A.U., Baris Y.I., Dogan M., Emri S., Steele I., Elmishad A.G., et al. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res 2006, 66:5063-5068.
11. de Klerk N., Alfonso H., Olsen N., Reid A., Sleith J., Palmer L., et al. Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia. Int J Cancer 2012.
12. Neri M., Ugolini D., Dianzani I., Gemignani F., Landi S., Cesario A., et al. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat Res Rev Mutat 2008, 659:126-136.
13. Stranger B.E., Stahl E.A., Raj T. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 2011, 187:367-383.
14. James A.L., Knuiman M.W., Divitini M.L., Hui J., Hunter M., Palmer L.J., et al. Changes in the prevalence of asthma in adults since 1966: the Busselton health study. Eur Respir J 2010, 35:273-278.
15. de Klerk N.H., Musk A.W., Ambrosini G.L., Eccles J.L., Hansen J., Olsen N., et al. Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene. Int J Cancer 1998, 75:362-367.
16. Musk A.W., de Klerk N.H., Ambrosini G.L., Eccles J.L., Hansen J., Olsen N.J., et al. Vitamin A and cancer prevention I: observations in workers previously exposed to asbestos at Wittenoom, Western Australia. Int J Cancer 1998, 75:355-361.
17. Betti M., Ferrante D., Padoan M., Guarrera S., Giordano M., Aspesi A., et al. XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study. Mutat Res 2011, 708:11-20.
18. Ugolini D., Neri M., Ceppi M., Cesario A., Dianzani I., Filiberti R., et al. Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor. Mutat Res 2008, 658:162-171.
19. Dianzani I., Gibello L., Biava A., Giordano M., Bertolotti M., Betti M., et al. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. Mutat Res 2006, 599:124-134.
20. Moffatt M.F., Gut I.G., Demenais F., Strachan D.P., Bouzigon E., Heath S., et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010, 363:1211-1221.
21. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575.
22. Patterson N., Price A.L., Reich D. Population structure and eigenanalysis. PLoS Genet 2006, 2:e190.
23. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006, 38:904-909.
24. Li Y., Willer C.J., Ding J., Scheet P., Abecasis G.R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010, 34:816-834.
25. R Core Team R: a language and environment for statistical computing 2012, R Foundation for Statistical Computing, Vienna, Austria.
26. Pruim* R.J., Welch* R.P., Sanna S., Teslovich T.M., Chines P.S., Gliedt T.P., et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010, 26:2336-2337.
27. Patino-Lopez G., Hevezi P., Lee J., Willhite D., Verge G.M., Lechner S.M., et al. Human class-I restricted T cell associated molecule is highly expressed in the cerebellum and is a marker for activated NKT and CD8+ T lymphocytes. J Neuroimmunol 2006, 171:145-155.
28. Umetsu D.T., DeKruyff R.H. Natural killer T cells are important in the pathogenesis of asthma: the many pathways to asthma. J Allergy Clin Immunol 2010, 125:975-979.
29. Garay E., Patino-Lopez G., Islas S., Alarcon L., Canche-Pool E., Valle-Rios R., et al. CRTAM: a molecule involved in epithelial cell adhesion. J Cell Biochem 2010, 111:111-122.
30. Du R., Litonjua A.A., Tantisira K.G., Lasky-Su J., Sunyaev S.R., Klanderman B.J., et al. Genome-wide association study reveals class I MHC-restricted T cell-associated molecule gene (CRTAM) variants interact with vitamin D levels to affect asthma exacerbations. J Allergy Clin Immunol 2012, 129:368-373. 373 e1-5.
31. Yoon S., Woo S.U., Kang J.H., Kim K., Shin H.J., Gwak H.S., et al. NF-kappaB and STAT3 cooperatively induce IL6 in starved cancer cells. Oncogene 2012, 31:3467-3481.
32. Bosco N., Pelliccia F., Rocchi A. Characterization of FRA7B, a human common fragile site mapped at the 7p chromosome terminal region. Cancer Genet Cytogenet 2010, 202:47-52.
33. Calvo F., Sanz-Moreno V., Agudo-Ibanez L., Wallberg F., Sahai E., Marshall C.J., et al. RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation. Nat Cell Biol 2011, 13:819-826.
34. Carbone M., Yang H. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clin Cancer Res 2012, 18:598-604.
35. Ladanyi M., Zauderer M.G., Krug L.M., Ito T., McMillan R., Bott M., et al. New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment. Clin Cancer Res 2012, 18:4485-4490.